QUALITÉ & PURETÉKO Validation?Knockout-validated — antibody specificity confirmed using knockout cells/tissue. Use when you need strong evidence the antibody binds only its target.
Recombinant EIF2AK2 Antibody - Anticorps primaire, specific to EIF2AK2
Spécifications et pureté
KO Validation
Espèce hôte
Lapin
Spécificité
EIF2AK2
Immunogène
A synthesized peptide derived from human PKR
Conjugation
Unconjugated
Grade
KO Validation
Méthode de purification
Protein A purified
Product Line
Produits biologiques
Stockage et expédition
Conditions de stockage de stockage
Store at -20°C,Avoid repeated freezing and thawing
Expédié en
Ice chest + Ice pads
Stabilité et stockage
Store at -20°C for one year.
Données avancées
Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calculateurs de solution
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
Reconstitution Calculator
Avis
Avis des clients
Application Protocols
Item-specific tested applications, species, and recommended dilutions: Not specified for this item; refer to CoA/Spec Sheet.
General workflow guidance (non-parameterized)
Western blot: Prepare lysates, resolve by SDS-PAGE, transfer to membrane, block, incubate with the primary antibody, wash, and detect with an appropriate species/isotype-matched secondary. Include WT vs KO controls when available.
Immunoprecipitation: Incubate lysate with antibody and capture on protein A/G matrix; wash and elute under native or denaturing conditions as needed.
IF/ICC: Fix, permeabilize, block, incubate with primary, wash, and detect with fluorescent secondary; counterstain nuclei/cytoskeleton as appropriate.
ELISA: Coat plates with capture reagent, block, add samples/standards, detect with antibody pair and enzyme-labeled secondary.
Notes
Because isotype/host, epitope, and working dilutions are not provided in the Product Data, select secondaries and conditions based on the CoA/Spec Sheet once available. Always include appropriate negative/positive controls and validate on your specific samples.
Biological Roles
Target overview (literature)
EIF2AK2 (also known as PKR) is a dsRNA-activated serine/threonine protein kinase that phosphorylates the alpha subunit of eukaryotic initiation factor 2 (eIF2α) at Ser51. This inhibits eIF2B-mediated GDP–GTP exchange, attenuating translation initiation as part of the integrated stress response.
Pathways and functions (literature)
Antiviral innate immunity: Activated by viral double-stranded RNA or interferon-inducible modulators, PKR limits viral replication by shutting down host and viral protein synthesis and can induce apoptosis.
Stress signaling: PKR integrates inputs from cellular stressors (ER stress, oxidative stress) to modulate translation and gene expression, intersecting with PERK/GCN2/HRI pathways.
Crosstalk: PKR activity influences NF-κB signaling, MAPK pathways, and inflammasome components, linking translational control to inflammatory responses.
Substrates and interactors: Primary substrate is eIF2α; additional reported interactions include PACT (PRKRA), TRBP, and components of stress granules (literature).
Experimental implications (general)
Measuring EIF2AK2 protein levels with antibodies complements phospho‑eIF2α readouts and kinase activity assays to map pathway activation.
KO or knockdown models help confirm on-target antibody detection and delineate PKR-dependent effects.
Caveats
EIF2AK2 activation state and localization are stimulus-dependent; sample handling (presence of phosphatase inhibitors, induction conditions) critically affects data interpretation.
Note: This section summarizes biological context from literature and does not imply any clinical or diagnostic use.
Buffer Applications
Item-specific buffer information
Composition, pH, and excipients: Not specified for this item; refer to CoA/Spec Sheet.
General guidance (antibody workflows)
Storage/handling: PBS (10 mM phosphate, 137 mM NaCl, 2.7 mM KCl, pH 7.2–7.4) or TBS (20–50 mM Tris, 150 mM NaCl, pH 7.4–8.0) are common antibody carriers.
Blocking/wash buffers: TBST or PBST with 0.05–0.1% Tween-20 reduces nonspecific binding in immunoassays. Blocking agents can include 3–5% BSA, nonfat milk, or serum depending on assay and secondary.
Enzyme compatibility: If using HRP conjugates, avoid sodium azide in assay buffers as it inhibits peroxidase.
Sample buffers: For WB, denaturing Laemmli buffer with reducing agent for total EIF2AK2; for native IP, use mild, non-denaturing lysis buffers with protease/phosphatase inhibitors.
Note
This product’s exact buffer composition and any preservatives are not provided in the Product Data. Verify compatibility with your downstream application and adjust via buffer exchange/dialysis if necessary.
Green Alternatives
This product is a protein-based antibody reagent, not a bulk chemical solvent or catalyst; green-chemistry substitution frameworks are not typically applicable.
General sustainability considerations (laboratory practice)
Minimize waste by aliquoting only what is needed and avoiding repeated freeze–thaw that leads to discard.
Use reusable cold packs and insulated shippers (as supplied: Ice chest + Ice pads) to reduce single-use dry ice where appropriate for stability.
Prefer phosphate- or Tris-based buffers prepared with deionized water, and avoid environmentally persistent biocides when not required by the protocol. If preservatives are present (not specified for this item), ensure proper disposal to prevent aquatic toxicity.
Consolidate shipments and coordinate ordering to reduce packaging and transport emissions.
Employ digital documentation in lieu of printed SOPs to reduce paper use.
If buffer exchange is required (general)
Choose low-waste buffer exchange methods such as centrifugal ultrafiltration devices that can be reused multiple times.
Scale experiments to the minimum volume necessary to conserve reagents and consumables.
Note: There are no direct “greener alternatives” to the antibody itself; performance depends on antigen specificity. Optimization of experimental design and resource use provides the primary sustainability gains.
Pharmaceutical Uses
This product is an antibody reagent intended strictly for research use only; no clinical or therapeutic applications are claimed or supported.
General, non-clinical uses in pharmaceutical R&D (literature/practice)
Target validation: Detect EIF2AK2 levels in cell lines or tissues to assess pathway engagement during antiviral or stress-response studies.
Mechanism-of-action studies: Pair EIF2AK2 detection with phospho‑eIF2α quantification and translation readouts to evaluate compound effects on the integrated stress response.
Biomarker assay development: Serve as a capture or detection reagent in research-grade ELISAs for preclinical translational studies (not for diagnostic use).
Bioprocess analytics: Antibodies may be employed in QC-style assays (e.g., WB, ELISA) to standardize lot characterization of cellular materials.
Regulatory note
Not intended for use in humans or animals for therapeutic or diagnostic purposes.
No pharmacopeial monograph or GMP status is provided for this item. Any qualification for regulated workflows would require independent user validation and documentation.
Item-specific statement
There are no item-specific pharmaceutical/formulation specifications in the Product Data; consult CoA/Spec Sheet if additional documentation becomes available.
Physical Properties
Item-specific properties
Appearance: Not specified for this item; refer to CoA/Spec Sheet.
Concentration, buffer composition, protein content (µg/mL or mg/mL): Not specified for this item; refer to CoA/Spec Sheet.
pH, excipients (e.g., glycerol, BSA, azide), preservative: Not specified for this item; refer to CoA/Spec Sheet.
Literature/general values (context; not item specifications)
Molecular mass: Typical full-length IgG antibodies are ~150 kDa; Fab fragments ~50 kDa; scFv ~25–30 kDa (literature). Actual mass for this item is not specified.
Isoelectric point (pI): Antibodies commonly exhibit pI ~6–9 depending on isotype/sequence (literature).
Solubility: Antibodies are soluble in aqueous physiological buffers (e.g., PBS, TBS) at mg/mL levels; stability may improve with additives such as 10–50% glycerol or carrier proteins (literature).
Stability: Antibody tertiary structure is maintained near neutral pH and refrigerated temperatures; repeated freeze–thaw can reduce activity via aggregation/denaturation (literature).
Optical properties: Protein concentration often measured at A280 nm using extinction coefficients derived from sequence; exact ε for this item is not specified.
Practical notes (general)
Avoid foaming and vigorous vortexing that introduce air interfaces.
For long-term storage, aliquoting minimizes freeze–thaw cycles. Use low-protein-binding plastics to reduce surface loss.
If lyophilized, gentle reconstitution in the specified buffer at recommended concentration is advised (parameters not provided for this item).
Quality and Grades
Item-specific detail
Grade/Purity: KO Validation (provided by manufacturer).
Interpretation (general; not item-specific guarantees)
KO (knockout) validation indicates the antibody’s target specificity has been orthogonally evaluated in a biological system lacking the target gene/protein (gene knockout or CRISPR/Cas9 null line). A KO-validated antibody should show loss or significant reduction of signal in KO samples relative to WT under the validated application conditions. This strengthens confidence in on-target binding and reduces risk of off-target detection.
Important: KO validation is application- and condition-specific. Performance can vary with sample preparation, species, fixation, and detection platforms. Always confirm suitability under your own experimental conditions.
Additional quality considerations (general)
Lot-to-lot consistency: Recombinant antibodies typically offer improved sequence-defined consistency compared with hybridoma-derived monoclonals.
Purity and contaminants: Common purification methods include protein A/G affinity and size-exclusion; residual host proteins, nucleic acids, and endotoxin levels are controlled per internal specs. For this item, exact purity %, endotoxin, and residuals are Not specified for this item; refer to CoA/Spec Sheet.
Formulation factors: Presence of stabilizers (e.g., glycerol), carriers (e.g., BSA), and preservatives (e.g., azide) impact storage and certain applications (e.g., azide inhibits peroxidase). These are Not specified for this item; refer to CoA/Spec Sheet.
Documentation
For verified application data, epitope information, isotype/host, and recommended dilutions, consult the item-specific CoA/Spec Sheet.
Reaction and Applications
Not a chemical reagent for synthetic reactions. Instead, this product is an affinity reagent for protein detection and characterization.
Research applications (general; literature)
Western blotting (WB): Detect EIF2AK2 in cell/tissue lysates; KO validation (grade indicated) supports specificity assessment when comparing WT vs KO samples under validated conditions.
Immunoprecipitation (IP)/Co-IP: Enrich EIF2AK2 and interacting partners to study signaling complexes, kinase activation, and phosphorylation events in stress responses.
Immunofluorescence (IF)/Immunocytochemistry (ICC): Localize EIF2AK2 subcellular distribution, including cytoplasmic vs stress-granule association upon dsRNA or interferon stimulation.
ELISA/Sandwich assays: Quantify EIF2AK2 in extracts; requires suitable capture/detection pair if using two antibodies.
Sample prep: Use lysis buffers that preserve protein complexes if IP is intended; include phosphatase inhibitors when monitoring phosphorylation states.
Controls: Include KO or siRNA knockdown controls where feasible; also consider peptide competition if epitope is known (not specified for this item).
Detection: Match secondary antibody to isotype/host of this primary; these details are Not specified for this item—consult CoA/Spec Sheet.
Note: Specific validated applications, species reactivity, and working dilutions for this item are Not specified for this item; refer to CoA/Spec Sheet.
Reaction Conditions
Not applicable to chemical reactions. As an analytical biological reagent, the antibody’s “conditions of use” pertain to immunoassay protocols rather than stoichiometric/catalytic chemical reactions.
General immunoassay context (no item-specific parameters provided)
Western blot: Typical workflows include SDS-PAGE, transfer to PVDF/nitrocellulose, blocking, primary antibody incubation, washes, and secondary detection. Incubation times, temperatures, and dilutions are assay-dependent and Not specified for this item; refer to CoA/Spec Sheet.
Immunoprecipitation: Incubation of clarified lysate with antibody and protein A/G resin at 4 °C is standard; buffer salt strength and detergents are tuned to preserve complexes. Specific conditions are Not specified for this item.
IF/ICC: Fixation (PFA or methanol), permeabilization, blocking, and antibody incubation vary by cell type/epitope; parameters are Not specified for this item.
Note
For authoritative, application-specific conditions (dilutions, incubation times, species tested, positive controls), consult the product CoA/Spec Sheet when available.
Safety and Handling
Item-specific safety data
GHS signal word, hazard statements, pictograms: Not specified for this item; refer to SDS.
Research use: For research use only (not for diagnostic or therapeutic use).
General laboratory guidance for protein antibodies (literature/practice)
PPE: Wear lab coat, gloves, and safety glasses when handling solutions. Avoid aerosol generation. Work in a clean area to prevent contamination.
Biosafety: Although recombinant antibodies are non-infectious, handle as biological materials using good microbiological practices. Disinfect work surfaces after use.
Incompatibilities: Avoid strong oxidizers and extremes of pH that may denature proteins. High shear and repeated freeze–thaw can cause aggregation.
First aid overview: In case of contact with eyes/skin, rinse with water. If inhaled (aerosol), move to fresh air. If ingested, rinse mouth and seek advice per institutional policy. Consult SDS for authoritative instructions.
Spill response: Absorb aqueous spills with inert material, clean with detergent/disinfectant, and dispose per institutional bio-waste protocols.
Waste disposal: Collect unused material and contaminated consumables as biological lab waste; follow local regulations and your EHS guidance.
Notes
Preservatives (e.g., sodium azide) and carrier proteins (e.g., BSA) may be present in some antibody formulations, which can affect handling and disposal; however, for this specific item such components are not specified—consult the CoA/SDS.
Solvent Selection
Item-specific formulation
Buffer/solvent: Not specified for this item; refer to CoA/Spec Sheet.
General guidance for antibody solvents (literature/practice)
Preferred media: Physiological, isotonic buffers such as PBS (pH ~7.2–7.4) or TBS (pH ~7.4–8.0) help maintain antibody stability and activity. Additives like 10–50% glycerol (cryoprotectant), 0.01–0.1% carrier protein (e.g., BSA), and mild detergents (e.g., 0.01% Tween-20) are sometimes used depending on application.
Avoid: Strong organic solvents (acetonitrile, methanol, DMSO) and extreme pH/ionic strengths that denature or precipitate proteins. If conjugation chemistry is planned, choose additive-free buffers compatible with crosslinkers (e.g., amine-free for NHS ester reactions).
Filtration: Use 0.22–0.45 µm low-protein-binding filters for clarification. Minimize shear.
When to choose alternatives
For freeze–thaw sensitive antibodies, formulate in aliquots with glycerol and store at −20 °C to avoid ice crystal damage.
For peroxidase-based detection, avoid azide-containing buffers that inhibit HRP; use azide-free formulations or dialyze/exchange buffer before use.
Small comparison (general)
PBS vs TBS: TBS can reduce nonspecific ionic interactions in some immunoassays; PBS is widely compatible with cells/tissues. Choice often depends on assay optimization and antigen properties.
Storage and Reconstitution
Item-specific storage and shipping (from Product Data)
Storage conditions: Store at −20 °C. Avoid repeated freezing and thawing.
Shipping: Shipped in an ice chest with ice pads.
Item-specific formulation/reconstitution
Reconstitution status, buffer composition, concentration: Not specified for this item; refer to CoA/Spec Sheet.
General best practices (literature/practice; not item specifications)
Upon receipt: Inspect for container integrity. If lyophilized, briefly centrifuge vial before opening to collect contents. Reconstitute gently with sterile, neutral pH buffer (e.g., PBS or recommended buffer) to the desired concentration; avoid vigorous mixing.
Aliquoting: Divide into single-use aliquots in low-protein-binding tubes to prevent freeze–thaw cycles. For long-term storage, many antibodies remain stable at −20 °C with 30–50% glycerol; do not freeze at −80 °C when high glycerol is present to avoid solidification. These additives are not specified for this item—adjust only if compatible with your application.
Handling: Keep on ice during use. Avoid prolonged room-temperature exposure and foaming.
Stability monitoring: If performance drifts, consider clarifying by brief centrifugation, checking for microbial contamination, and confirming concentration by A280.
Disposal
Dispose of unused material and consumables as laboratory bio-waste per institutional and local regulations.
Structure and Identity
Item-specific facts (from Product Data)
SKU: Ab325701
Product name: Recombinant EIF2AK2 Antibody
Category: 抗体 (Antibody)
Grade/Purity designation: KO Validation
Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.
SMILES / InChIKey: Not applicable to protein biologics; not specified for this item.
General description (antibody/target; literature)
Antibody class: Recombinant monoclonal or recombinant polyclonal format not specified. Antibodies are Y‑shaped immunoglobulins composed of two heavy and two light chains with variable regions conferring antigen specificity; typical formats include full-length IgG, scFv, or recombinant fragments (Fab, F(ab’)2). Isotype/host are not provided for this item (refer to CoA/Spec Sheet).
Target: EIF2AK2 (Protein kinase R, PKR), a dsRNA-activated serine/threonine kinase that phosphorylates eIF2α to modulate translation initiation (literature).
Structural features (literature)
Typical full-length IgG contains disulfide‑bonded domains (CH1–CH3, CL) and antigen-binding complementarity-determining regions (CDRs) within VH/VL. Glycosylation patterns may be present in recombinant IgGs depending on expression system.
EIF2AK2 antigen epitopes often reside within catalytic or regulatory domains; antibody epitope for this item is not specified (refer to CoA/Spec Sheet).
2D/functional depiction in words (literature)
The antibody comprises two antigen-binding sites that recognize specific EIF2AK2 epitope(s) via noncovalent interactions (H-bonding, electrostatic, hydrophobic) and a constant region that mediates Fc-dependent functions if present (isotype not specified).
Synthetic Utility
Not applicable. This product is a recombinant antibody directed against EIF2AK2 and is not used as a synthetic building block, catalyst, or reagent in chemical transformations.
Guidance
For chemists working at the biology–chemistry interface, the antibody may be used analytically to evaluate cellular target engagement of small molecules that modulate EIF2AK2-related pathways, but it does not participate in chemical synthesis.
See also
Reaction & Applications and Biological Roles sections for relevant experimental usage in immunoassays and pathway studies.
Clone, isotype, host species, epitope, species reactivity, and validation datasets: Not specified for this item; refer to CoA/Spec Sheet.
General context (literature; not item-specific claims)
EIF2AK2 is a dsRNA-activated serine/threonine kinase that phosphorylates eIF2α, regulating translation initiation during stress and innate immune responses.
Important
Because the determinant epitope, isotype, and tested applications are not provided in the Product Data, users should verify specificity under their conditions, ideally employing KO/knockdown controls consistent with the KO Validation grade described.
Foire aux questions
What does KO Validation mean?
KO Validation indicates the product has been validated for use in rigorous antibody validation workflows. Validation may include positive/negative control samples, signal-to-noise testing, and protocol-specific QC. Lot-specific test data is published on the Certificate of Analysis where available.
How should this product be stored?
Store at ?20 °C. Avoid repeated freeze–thaw cycles. Aliquot into single-use volumes before freezing.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.
Besoin d'aide pour choisir la qualité ?
Notre guide de sélection des qualités couvre la pureté, le statut du stabilisant et l'adéquation à l'application pour toutes les variantes de notre catalogue.
Nous utilisons des cookies pour garantir le bon fonctionnement du site et, lorsque cela est autorisé, pour améliorer votre expérience. Vous pouvez gérer vos préférences à tout moment dans les Paramètres. Pour en savoir plus, consultez notre Politique relative aux cookies.
Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?
Me rappeler plus tard
Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.